Cirrhosis has a huge impact in the quality of life of patients and the healthcare and economic systems. The EF Clif researchers have contributed to characterize and find the predictors and mechanisms involved in the development and clinical course of ACLF, which will help to prevent and treat ACLF in a near future.
The May issue of Journal of Hepatology makes a complete review of the Decompensated cirrhosis and the new concepts and perspective, related to the diagnosis and treatment of these patients.
https://www.journal-of-hepatology.eu/issue/S0168-8278(21)X0006-2